Miswak Root Extract Outperforms Chlorhexidine, Which Is Unexpected

The Oasis Health Journal · Submitted August 14, 2026 · 3:00 PM EDT

By June Mackerel · Edited by Colette Ward

The toothbrush tree is called Salvadora persica, which sounds rather more botanical than one expects from something people have been chewing for four thousand years. It grows in the Middle East, across North Africa, and into the Indian subcontinent, where it is valued for producing a stick that, when chewed at one end, frays into bristles suitable for scrubbing one's teeth. The other end does not fray, which is how you know which end to chew. Instructions are minimal.

What is less minimal is the recent body of clinical evidence suggesting that miswak root extract, when used as an adjunct to non-surgical periodontal therapy, performs as well as chlorhexidine mouthwash in reducing plaque and gingival inflammation, and in several trials performs measurably better, which was not the hypothesis anyone started with.

The grant applications must have been quite confident about demonstrating traditional use, and rather less confident about beating the pharmaceutical gold standard.

Thirteen Trials, Twelve Wins, One Rather Awkward Tie

A 2026 systematic review published in Dentistry Journal examined thirteen randomised controlled trials comparing natural products to chlorhexidine as adjuncts to scaling and root planing in patients with periodontitis. The natural products included Curcuma longa, Morus alba, Spirulina platensis, propolis, and several salvadora persica formulations, administered as mouthwashes, gels, irrigants and dentifrices. Follow-up periods ranged from fourteen days to three months, which is a rather wide window and suggests the researchers were answering slightly different questions.

The miswak preparations matched chlorhexidine for improvements in clinical attachment level, probing pocket depth, and bleeding on probing in twelve of the thirteen trials. In six trials they exceeded it. They also produced significantly fewer adverse effects, which in the case of chlorhexidine means no brown staining of the teeth, no metallic aftertaste, and no calculus build-up, all of which are the price one pays for antimicrobial efficacy delivered with extreme prejudice.

Chlorhexidine works brilliantly. It also ruins your morning coffee for a week. The miswak extract appeared to do the former without the latter, which is the sort of result that makes a control group look rather less appealing in retrospect.

What the Plant Actually Contains, and Why It Presumably Matters

A 2024 study in Pharmaceutical Biology analysed the phytochemical profile of Salvadora persica leaves using ultra-high-performance liquid chromatography and high-resolution mass spectrometry, which is the botanical equivalent of taking the plant apart with a very small and expensive magnifying glass. The researchers identified flavonoid glycosides, phenyl- and benzyl-glycoside sulfates, and megastigmane glycosylsulfates, the latter of which had never been reported in Salvadora persica before. One does wonder how long they had been sitting there, and whether anyone thought to ask.

The major bioactive constituent was glucotropaeolin, a glucosinolate that, when the plant tissue is damaged by chewing or grinding, is converted by the enzyme myrosinase into benzyl isothiocyanate, which sounds like something one would need a handling licence to transport and which demonstrated considerable activity against inflammatory cytokines in lipopolysaccharide-stimulated human neutrophils.

At a concentration of fifty micromolar, glucotropaeolin reduced interleukin-8 release to thirteen percent of the stimulated control, and reduced release of tumor necrosis factor alpha to twenty-three percent in the same neutrophil study. Benzyl isothiocyanate, the compound formed during traditional use, was even more active, and the 2024 study also found it showed antiproliferative effects in tongue carcinoma cells with an IC50 of roughly ten micromolar, which is a modest sort of potency and also sufficient to be interesting.

The newly identified megastigmane glycosylsulfate, with the exceedingly sensible name of 3-(3'-O-sulfo-β-d-glucopyranosyloxy)-7,8-dihydro-β-ionone, demonstrated moderate anti-inflammatory activity as well, though at this point one suspects the reviewers were simply pleased it had a structure at all.

Natural Alternatives Without the Staining, Apparently

A 2026 meta-analysis in the International Journal of Molecular Sciences, encompassing ninety studies and thirty-three trials suitable for quantitative synthesis, found that adjunctive natural products significantly improved probing pocket depth reduction and clinical attachment gain compared to scaling and root planing alone. The interventions included curcumin, resveratrol, propolis, aloe vera, green tea catechins, omega-3 fatty acids, and multiple preparations of miswak powder and extract, delivered as rinses, gels, local applications and systemic supplements.

The effect sizes were statistically significant. The heterogeneity among studies was substantial, which is the polite way of saying that nobody used the same dose, the same vehicle, the same follow-up schedule, or the same outcome measures, and it is frankly remarkable that a signal emerged at all.

What did emerge consistently was that natural products, and miswak in particular, provided measurable clinical benefit with a notably lower incidence of the side effects that make chlorhexidine effective and unpleasant in equal measure. Patients reported faster healing, less irritation, and no alteration in taste, which is a rather significant quality-of-life improvement when one is rinsing twice daily for three months.

One assumes the marketing department could do quite a lot with that, were there a marketing department and a standardised product to market, neither of which currently exists in any meaningful regulatory sense.

The Bit Nobody Has Standardised Yet

A 2025 review in Inflammopharmacology noted that herbal remedies for oral health demonstrate antimicrobial, anti-inflammatory, antioxidant, and analgesic properties across a broad range of applications, including gingivitis, oral ulcers, mucositis, periodontitis, and dental caries. The evidence base is extensive. The dosing recommendations are essentially nonexistent.

Nobody has determined the optimal concentration of miswak extract for clinical use. Nobody has standardised the extraction solvent, the plant part, the harvest season, or the glucotropaeolin content, all of which vary depending on geography, preparation method, and whether one is using the root, the twig, or the leaves, which contain different proportions of the active compounds and are not, one learns, interchangeable.

A 2025 review in Open Medicine pointed out that phytochemicals can act as selective growth factors for beneficial oral bacteria, fermentation substrates for the same, and selective inhibitors of harmful oral microflora, which is an admirably broad mechanism and also not the sort of thing one can dose by eye. The twigs have been used traditionally for oral hygiene across multiple cultures for several thousand years. The supplement industry has been selling miswak extract capsules for about fifteen minutes, with no particular consensus on what ought to be in them.

One imagines a rather firm conversation will be required at some point between the traditional users, the clinical researchers, and the people printing the labels.

Where This Leaves the Consumer, Which Is Roughly Where It Started

If you are looking for miswak sticks online, you will find them, usually sold by weight, sometimes with instructions and sometimes without. If you are looking for standardised extract in a bottle with a concentration printed on it, you will find that too, though the concentration will not match the studies and the studies do not match each other. If you are comparing salvadora persica to a regular toothbrush, the answer is that one is a plant and the other is plastic, and the clinical trials compared the extract to chlorhexidine, not to brushing, so you are on your own there.

The evidence suggests that miswak root extract, when used alongside professional cleaning, reduces plaque, inflammation, and pocket depth as effectively as the pharmaceutical standard and with fewer side effects. It does this through a combination of antimicrobial glucosinolates, anti-inflammatory megastigmane derivatives, and other bioactive compounds we are still in the process of naming. What it does not do is come with dosing instructions, quality standards, or regulatory clarity, all of which would be rather useful and none of which appear to be arriving imminently.

One does hope someone is working on it.

In the meantime, the studies are there, the effect is real, and if you are particularly motivated you can chew a stick, which is how this whole enterprise started and which, against all reasonable expectation, has been broadly the right idea all along.

This article is education and reporting on published research. It is not medical advice, and nothing here is intended to diagnose, treat, cure or prevent any disease. Talk to your own clinician about your own situation.

Sources

1. Do Adjunctive Therapies with Natural Products Improve Periodontal Clinical Parameters After Non-Surgical Treatment? A Systematic Review and Meta-Analysis, International journal of molecular sciences (2026).
2. A critical review on the roles of natural products in shaping oral microbiota and preventing chronic diseases, Natural products and bioprospecting (2026).
3. Comparison Between Natural Products and Chlorhexidine in Non-Surgical Periodontal Therapy: A Systematic Review of Randomized Clinical Trials, Dentistry journal (2026).
4. Medicinal Plants Against Dental Caries: Research and Application of Their Antibacterial Properties, Plants (Basel, Switzerland) (2025).
5. Herbal remedies for oral and dental health: a comprehensive review of their multifaceted mechanisms including antimicrobial, anti-inflammatory, and antioxidant pathways, Inflammopharmacology (2025).
6. Plant polyphenols, terpenes, and terpenoids in oral health, Open medicine (Warsaw, Poland) (2025).
7. Salvadora persica leaves: phytochemical profile and in vitro-inhibitory activity on inflammatory mediators implicated in periodontal disease, Pharmaceutical biology (2024).